MFDS
- Marketing authorisation holder: CHIMERIX
- Status: likely_approved
🇰🇷 Modeyso in South Korea
Modeyso (DORDAVIPRONE) regulatory status in South Korea.
Marketing authorisation
Modeyso in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Modeyso approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Modeyso in South Korea?
CHIMERIX holds the South Korean marketing authorisation.